Clinical Trial Update: A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia [Phase 3]

View source ↗

Summary

Phase III trial comparing H077 sustained-release tablets to silodosin capsules for benign prostatic hyperplasia. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms

Drugs mentioned

• H077 sustained-release tablets
• Rapaflo (silodosin)

Snippet

Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd. | Conditions: Benign Prostatic Hyperplasia, Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms | Phase 3 | Status: NOT_YET_RECRUITING